2004
DOI: 10.1016/j.jaci.2003.09.051
|View full text |Cite
|
Sign up to set email alerts
|

Systemic effects of local allergic disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
84
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 95 publications
(87 citation statements)
references
References 61 publications
3
84
0
Order By: Relevance
“…1,2 Moreover, allergic disorders such as allergic rhinitis or asthma have also been reported to be associated with atherosclerosis. 3 The coronary artery calcification (CAC) score has recently been developed as a marker of coronary atherosclerosis, which can be assessed noninvasively using multislice CT (MSCT). CAC is an established quantitative, objective measure of coronary artery atherosclerosis, and several studies have revealed a correlation between CAC and angiographic stenosis.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Moreover, allergic disorders such as allergic rhinitis or asthma have also been reported to be associated with atherosclerosis. 3 The coronary artery calcification (CAC) score has recently been developed as a marker of coronary atherosclerosis, which can be assessed noninvasively using multislice CT (MSCT). CAC is an established quantitative, objective measure of coronary artery atherosclerosis, and several studies have revealed a correlation between CAC and angiographic stenosis.…”
Section: Introductionmentioning
confidence: 99%
“…According to Togias, the mechanisms that lead instead to the development of the systemic element probably include intricate interactions between mediators of the acute allergic reaction, locally and systemically produced cytokines and neurotrophins, the vascular epithelium and the adhesion molecule system, the chemokine network and antigenpresenting cells and their interactions with T lymphocytes [12].…”
mentioning
confidence: 99%
“…Allergic diseases including bronchial asthma are not confined to the area where they originated but they involve also systemic circulation [21]. The present study demonstrates that BUD, an inhaled corticosteroid widely used for the management of bronchial asthma, controls asthma inflammation by modulating TLR2 and TLR4 and IL-10 expression in CD4þ/CD25highlyþ cells as well as IL-6 and TNF-a release in PBMC of asthmatics.…”
Section: Discussionmentioning
confidence: 52%